Temporal trends of survival and utilization of mechanical circulatory support devices in patients with in‐hospital cardiac arrest secondary to ventricular tachycardia/ventricular fibrillation

Background Pulseless ventricular tachycardia/ventricular fibrillation (VT/VF) is the initial rhythm in a third of in‐hospital cardiac arrest patients. Mechanical circulatory support (MCS) device use remains poorly understood in this population. Methods We conducted an observational analysis of tempo...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2019-10, Vol.94 (4), p.578-587
Main Authors: Patel, Nileshkumar J., Atti, Varunsiri, Kumar, Varun, Panakos, Andrew, Anantha Narayanan, Mahesh, Bhardwaj, Bhaskar, Arora, Shilpkumar, Deshmukh, Abhishek J, Patel, Nish, Basir, Mir B., Cohen, Mauricio G., Kini, Annapoorna S., Sharma, Samin K., Dangas, George, O'Neill, William W., Alfonso, Carlos E.
Format: Article
Language:English
Subjects:
Aorta
Cardiac arrest
Cardiac arrhythmia
Cardiopulmonary resuscitation
CPR
extracorporeal membrane oxygenator
Fibrillation
Heart
intra‐aortic balloon pump
mechanical circulatory support
percutaneous ventricular assist device
Population studies
Survival
Tachycardia
Trends
Ventricle
ventricular tachycardia/ventricular fibrillation‐in hospital cardiac arrest
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Pulseless ventricular tachycardia/ventricular fibrillation (VT/VF) is the initial rhythm in a third of in‐hospital cardiac arrest patients. Mechanical circulatory support (MCS) device use remains poorly understood in this population. Methods We conducted an observational analysis of temporal trends in the utilization of MCS in VT/VF IHCA between January 2008 and December 2014 utilizing the Nationwide Inpatient Sample (NIS) database. Using multivariable analysis, we assessed factors associated with MCS use and survival to discharge. Results Among 151,628 hospitalizations with VT/VF IHCA, 14,981 (9.9%) received MCS. Intra‐aortic balloon pump (IABP) was the most commonly used MCS (9.1%). From 2008 to 2014, there was significant increase in the utilization of MCS (8.7–11%; ptrend 
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.28138